Levocamed

Levocabastine Hydrochloride, the active ingredient in Levocamed, is an antihistamine presented as eye drops for ocular use. It alleviates allergic conjunctivitis and reduces ocular itching and redness caused by environmental allergens in adults and children. The product is marketed in the European Union and conforms to EU pharmacopeial standards.

GNH USA supplies Levocamed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across markets.

Levocamed is an ocular antihistamine that targets allergic inflammation of the conjunctiva. - Allergic conjunctivitis: reduces inflammation, itching and redness of the conjunctiva. - Ocular itching due to allergy: provides rapid relief of itch sensation. - Redness of the eye caused by allergy: diminishes vasodilation and visible redness.

Levocamed is generally well tolerated, but ocular antihistamines can cause local reactions.

Common Side Effects: - Transient stinging or burning sensation upon instillation. - Mild blurred vision lasting a few minutes. - Temporary eye irritation or foreign‑body feeling. - Mild headache. - Dry eye sensation. - Increased tear production.

Serious or Rare Side Effects: - Allergic contact dermatitis of the eyelid or peri‑ocular skin. - Severe eye pain or swelling. - Vision loss or sudden visual disturbances. - Anaphylactic reaction requiring emergency care.

Before using Levocamed, consider the following safety measures. - Pregnancy: safety not established; consult a healthcare professional before use. - Breastfeeding: unknown safety profile; use with caution. - Contact lens wearers: remove lenses before instillation and wait several minutes before reinserting. - Known hypersensitivity: avoid if allergic to Levocabastine or any excipient. - Active ocular infection: do not use without physician guidance. - Store at room temperature: keep in the original container, protect from light and moisture.

Levocamed may interact with other ocular or systemic agents.

Major Interactions (Avoid): - Concurrent use of multiple ocular antihistamines may increase local irritation. - Co‑administration with ophthalmic vasoconstrictors can potentiate vasoconstrictive effects.

Moderate Interactions (Monitor Closely): - Systemic antihistamines may add to overall antihistaminic load, potentially causing drowsiness. - Use with other eye drops containing preservatives may increase risk of ocular surface irritation. - Topical corticosteroids may mask signs of infection; monitor closely.